Accessibility Menu
Pro Medicus logo

Pro Medicus

(ASX) PME

Current PriceA$164.00
Market CapA$17.13B
Since IPO (2000)+20,229%
5 Year+232%
1 Year-41%
1 Month+31%

Pro Medicus Financials at a Glance

Market Cap

A$17.13B

Revenue (TTM)

A$425.15M

Net Income (TTM)

A$332.98M

EPS (TTM)

A$2.24

P/E Ratio

73.01

Dividend

A$0.62

Beta (Volatility)

-0.03 (Low)

Price

A$164.00

Volume

174,469

Open

A$165.92

Previous Close

A$164.00

Daily Range

A$162.49 - A$166.34

52-Week Range

A$107.75 - A$336.00

Estimated Earnings Date

Aug 19, 2026

PME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pro Medicus

Industry

Health Care Technology

Employees

132

CEO

Sam Aaron Hupert, MD

Headquarters

Richmond, VIC 3121, AU

PME Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

74%

Net Income Margin

98%

Return on Equity

77%

Return on Capital

37%

Return on Assets

44%

Earnings Yield

1.37%

Dividend Yield

0.38%

Payout Ratio

24.49%

Stock Overview

Market Cap

A$17.13B

Shares Outstanding

104.47M

Volume

174.47K

Avg. Volume

332.74K

Financials (TTM)

Gross Profit

A$212.60M

Operating Income

A$157.61M

EBITDA

A$164.85M

Operating Cash Flow

A$111.33M

Capital Expenditure

-A$7.38M

Free Cash Flow

A$103.96M

Cash & ST Invst.

A$209.19M

Total Debt

A$2.26M

Pro Medicus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$124.78M

+68.4%

Gross Profit

A$96.16M

+76.1%

Gross Margin

77.07%

N/A

Market Cap

A$17.13B

N/A

Market Cap/Employee

A$216.87M

N/A

Employees

79

N/A

Net Income

A$171.22M

+372.3%

EBITDA

A$94.31M

+72.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$223.59M

+68.7%

Total Debt

A$4.32M

+179.9%

Accounts Receivable

A$77.90M

+83.4%

Inventory

A$85.00K

+25.0%

Long Term Debt

A$3.56M

+80.0%

Short Term Debt

A$768.00K

+37.9%

Return on Assets

43.96%

N/A

Return on Invested Capital

36.81%

N/A

Free Cash Flow

A$69.13M

+150.1%

Operating Cash Flow

A$69.39M

+122.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FPH.AXFisher & Paykel Healthcare Corporation Limited
A$32.23+1.45%
COH.AXCochlear Limited
A$103.75+0.84%
SIG.AXSigma Healthcare Limited
A$2.64-1.86%
CGS.AXCogstate Limited
A$2.74-0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$124.57+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
SMCISuper Micro Computer
$30.46-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About PME

What is the current price of Pro Medicus?

Pro Medicus is trading at A$164.00 per share.

What is the 52-week range for Pro Medicus?

Over the past 52 weeks, Pro Medicus has traded between A$107.75 and A$336.00.

How much debt does Pro Medicus have?

As of the most recent reporting period, Pro Medicus reported total debt of A$2.26M.

How much cash does Pro Medicus have on hand?

Pro Medicus reported A$107.49M in cash and cash equivalents in its most recent financial results.

What is Pro Medicus’s dividend yield?

Pro Medicus currently has a dividend yield of 0.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.